We are live on ! Find out more
ADMS

Adamas Pharmaceuticals
ADMS

Delisted

ADMS was delisted on the 23rd of November, 2021.

Back to rankings

84 hedge funds and large institutions have $243M invested in Adamas Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

17% more capital invested

Capital invested by funds: $207M → $243M (+$36M)

0% more funds holding

Funds holding: 84 → 84 (0)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $332K

Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
2.24%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
14
Increased
30
Reduced
23
Closed
14
Calls
–
Puts
$332K
Net Calls
-$332K
Net Calls Change
-$369K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$8.95M
2
BS
Bow Street
New York
+$8.02M
3
BWCA
Brenner West Capital Advisors
New York
+$7.81M
4
BOS
Bingham Osborn & Scarborough
California
+$3.38M
5
JGC
J. Goldman & Co
New York
+$2.79M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$7.83M
2
CPH
C Partners Holding
Switzerland
-$3.3M
3
SM
Sabby Management
Florida
-$1.69M
4
IHM
Iguana Healthcare Management
New York
-$1.65M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.57M
Name Holding Trade Value Shares
Change 		Change in
Stake
RPAM
26
Rhenman & Partners Asset Management
Sweden
$1.97M +$2.14M +130,000 New
WSA
27
Wall Street Associates
California
$1.89M – – –
MFW
28
Mosaic Family Wealth
Missouri
$1.87M – – –
CCMU
29
Cheyne Capital Management (UK)
United Kingdom
$1.74M +$989K +60,000 +110%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.7M +$375K +22,733 +25%
IHM
31
Iguana Healthcare Management
New York
$1.51M -$1.65M -100,000 -50%
SM
32
Sabby Management
Florida
$1.48M -$1.69M -102,290 -51%
State of New Jersey Common Pension Fund D
33
State of New Jersey Common Pension Fund D
New Jersey
$1.42M – – –
PPA
34
Parametric Portfolio Associates
Washington
$1.1M +$544 +33 +0%
BIM
35
BlackRock Investment Management
Delaware
$1.03M +$303K +18,365 +37%
TC
36
TFS Capital
Pennsylvania
$943K +$1.03M +62,318 New
Dimensional Fund Advisors
37
Dimensional Fund Advisors
Texas
$917K +$21.4K +1,300 +2%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$912K +$178K +10,802 +22%
Manulife (Manufacturers Life Insurance)
39
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$903K -$49.5K -3,000 -5%
SCM
40
Sio Capital Management
New York
$855K +$602K +36,500 +183%
TCIM
41
TIAA CREF Investment Management
New York
$830K +$305K +18,499 +51%
ZIM
42
Zacks Investment Management
Illinois
$685K -$5.93K -360 -0.8%
OPPM
43
Opus Point Partners Management
New York
$684K -$145K -8,802 -16%
TAM
44
Tocqueville Asset Management
New York
$606K – – –
PAM
45
Private Asset Management
California
$590K – – –
TI
46
Trexquant Investment
Connecticut
$554K -$517K -31,383 -46%
Allianz Asset Management
47
Allianz Asset Management
Germany
$552K +$601K +36,476 New
CS
48
Credit Suisse
Switzerland
$532K -$141K -8,566 -20%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$530K +$151K +9,184 +36%
AA
50
ALPS Advisors
Colorado
$460K +$104K +6,296 +26%
1
2
3 4

ADMS Hedge Fund Activity: Q2 2016 in Review

84 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Adamas Pharmaceuticals (ADMS) for Q2 2016, worth a combined $243M — up 17% from $207M a quarter earlier.

Fund positioning in ADMS was balanced in Q2 2016: 14 funds opened new positions, 14 closed out, 30 added to existing stakes and 23 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.95M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $7.83M sold.

  • 84 institutional investors held Adamas Pharmaceuticals (ADMS) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $243M of Adamas Pharmaceuticals stock for Q2 2016, up 17% quarter-over-quarter.
  • 14 funds opened new Adamas Pharmaceuticals positions in Q2 2016 and 14 closed out, a net change of 0 holders.
  • The largest Adamas Pharmaceuticals buyer in Q2 2016 was Millennium Management, an estimated $8.95M added.
  • The largest Adamas Pharmaceuticals seller in Q2 2016 was Gilder Gagnon Howe & Co, an estimated $7.83M sold.

Based on aggregated 13F filings for Q2 2016.